Opinion · 30 Dec 2025
Mini reviewPublished 7 Mar 2022
A Review on Plasma Cell Leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plasma Cell Leukaemia (PCL) is a plasma cell dyscrasia, or a disease characterized by the malignant degeneration of plasma cells, a type of white blood cell. It is the most advanced and dangerous stage of these dyscrasias, accounting for 2% to 4% of all instances of plasma cell malignancies. PCL can manifest as either primary plasma cell leukaemia (in patients who have never had a plasma cell dyscrasia) or secondary plasma cell dyscrasia (in patients who have previously been diagnosed with multiple myeloma). Plasma Cell Leukemia (PCL) is a rare and aggressive kind of plasma cell dyscrasia that can develop from scratch (Primary Plasma Cell Leukaemia) or evolve from multiple myeloma that has already been detected and treated (secondary PCL). As a reminder of this diagnosis, we give three clinical examples with extremely distinct appearances. The cases also indicate the length and variability of a patient's journey, which is heavily reliant on financial capability and social support. Because the higher tumour load and more proliferative tumour cells, the clinical presentation is more aggressive, with more cytopenias and organomegaly. The diagnosis is based on the presence of circulating plasma cells in at least 20% of total white blood cells and a peripheral blood absolute plasma cell count of at least 2 109/l. In those who are transplant eligible, treatment with new medications followed by autologous stem cell transplant leads to better results.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Leukemia.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Leukemia
- SubjectHaematology
- BylineArticles whose byline prints “Sonia Erfani”

